Modern Chinese Medicine Group Co., Ltd. (Stock Code: 01643) announced that its Board of Directors will convene on 30 March 2026 (Monday). The meeting’s agenda includes:
• Approval of the audited annual results for the financial year ended 31 December 2025. • Consideration of a recommendation for a final dividend, if any.
The Board currently consists of six members: three executive directors—Sun Xinlei, Zhang Hongli and Jia Yanru—and three independent non-executive directors—Liu Ling, Leung Tsz Wing and Wong Chi Kin.
Any resolutions reached at the upcoming meeting, including potential dividend declarations, will be disclosed to the market after Board approval.
Comments